Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low-dose dopamine: a systematic review.

P E Marik1

  • 1Anesthesiology and Critical Care, Department of Critical Care Medicine, University of Pittsburgh Medical Center, 640A Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA. maripe@ccm.upmc.edu

Intensive Care Medicine
|July 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of copper-oxide-treated soft and hard surfaces on the incidence of healthcare-associated infections: a two-phase study.

The Journal of hospital infection·2020
Same author

The clinical characteristics and hospital and post-hospital survival of patients with the obesity hypoventilation syndrome: analysis of a large cohort.

Obesity science & practice·2016
Same author

Fluid therapy in 2015 and beyond: the mini-fluid challenge and mini-fluid bolus approach.

British journal of anaesthesia·2015
Same author

The demise of early goal-directed therapy for severe sepsis and septic shock.

Acta anaesthesiologica Scandinavica·2015
Same author

Fluid responsiveness: an evolution of our understanding.

British journal of anaesthesia·2014
Same author

The malignant obesity hypoventilation syndrome (MOHS).

Obesity reviews : an official journal of the International Association for the Study of Obesity·2012

Low-dose dopamine does not protect kidneys in patients with early renal injury. This meta-analysis found no significant benefit in preventing acute kidney dysfunction, suggesting it should not be used for renal protection.

Area of Science:

  • Nephrology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Acute kidney injury (AKI) is a common complication in critically ill patients.
  • Low-dose dopamine has been proposed as a renal-protective agent.
  • Evidence supporting its efficacy remains controversial.

Purpose of the Study:

  • To evaluate the effectiveness of low-dose dopamine in preserving renal function.
  • To determine if low-dose dopamine reduces the incidence of acute renal dysfunction.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials.
  • Included studies compared low-dose dopamine with placebo in patients at risk for or with early renal injury.
  • Data from 15 studies involving 970 patients were analyzed.

Related Experiment Videos

Main Results:

  • Low-dose dopamine did not significantly alter serum creatinine levels (mean difference 5.1 micromol/l).
  • The incidence of acute renal dysfunction was similar between dopamine and placebo groups (31% vs 33%).
  • No specific patient subgroup demonstrated a renal benefit from low-dose dopamine.

Conclusions:

  • This meta-analysis confirms that low-dose dopamine lacks a reno-protective effect.
  • Given potential adverse effects, low-dose dopamine is not recommended for preventing or treating renal dysfunction.